Independent Certified Sessions are educational programs organized by a
non-profit organization that offer continuing medical education (CME),
continuing nursing education (CNE) and/or continuing education (CE)
credit and for which no commercial support has been received.
Friday, March 27
Pregnancy and the Heart: What Every Clinician Needs to Know in 2026
Marriott Warehouse Arts District | Cypress Ballroom (2nd Floor)
–
Join Mayo Clinic for a complimentary evening of cardiovascular
obstetrics. Enjoy a dinner followed by an interactive case-based
discussion focused on cardiovascular disease in pregnancy, a leading
cause of maternal mortality.
Multidisciplinary evidence-based approaches to high-risk obstetric
cardiovascular conditions
Case-driven insights applicable to real-world clinical practice
Complimentary dinner and the opportunity to network with colleagues
This program is designed to support collaborative care and provide
practical strategies applicable to clinical practice.
Register today
.
advertisment
Prime Time Events
Prime Time Events are offered by companies and organizations at various
venues throughout New Orleans.
Friday, March 27 – Evening Events
4513. Impacting Patient Outcomes in ATTR-CM Through Early Recognition and Treatment
–
Hilton Riverside, Grand Ballroom D Sponsored by BridgeBio
Join this dynamic session featuring leading specialists who will share
insights on recent approaches in ATTR-CM diagnosis and management,
including ongoing gaps in care and emerging clinical data for a TTR
stabilizer in both variant and wild-type disease. This interactive
program will also welcome a patient with ATTR-CM who will share their
journey live, highlighting diagnostic challenges and their path to
patient advocacy.
4515. To Lead or Not to Lead, That Is the Question
–
Westin New Orleans Sponsored by Medtronic
This session explores LINQ's clinical impact and evolving applications,
bridging two decades of innovation with the latest insights on
arrhythmias in heart failure. Integrating expert perspectives on
real-world clinical judgment, attendees will discuss device selection
strategies across diverse patient profiles, connecting diagnostics to
therapeutic devices. Dinner will be served.
4514. Cracking the Code: Practical Encounters and Evolving Evidence in HF and CKD Care
–
Hilton Riverside, Grand Ballroom A, 1st Floor Sponsored by Boehringer Ingelheim
This live, in-person educational activity equips clinicians with
practical skills to improve care for patients with heart failure (HF)
and chronic kidney disease (CKD). Participants will learn to recognize
early indicators and risk factors for HF progression in patients with
or at risk for CKD; apply and optimize guideline-directed medical
therapy across HF phenotypes and CKD; and address common misconceptions
that delay appropriate treatment.
advertisment
Saturday, March 28 – Morning Events
4503. Voices of Change: Flyrcado in Action
–
Courtyard New Orleans Warehouse Arts District Sponsored by GE Healthcare
Join this breakfast panel where early adopters share how Flyrcado can
reshape cardiac imaging and care. Hear real-world stories from imagers
and referring cardiologists about its impact on clinical practice and
patient outcomes.
4501. Transthyretin Cardiac Amyloidosis: Integrating New Paradigms Into Cardiology Practice
–
Hilton Riverside, Grand Ballroom D Sponsored by The Mended Hearts for Alnylam
This educational program pairs real-world case scenarios with
practice-changing evidence to demonstrate best practices for
recognizing transthyretin cardiac amyloidosis, avoiding diagnostic
pitfalls and selecting therapy in a rapidly evolving treatment
landscape.
4502. Mastering the Intersection: Applying Non-Steroidal MRAs in Cardio-Kidney-Metabolic Disease
–
Hilton Riverside, Grand Ballroom A & B, 1st Floor Sponsored by Bayer
This symposium uses real-world cardiovascular-kidney-metabolic cases to
clarify when and how to use non-steroidal mineralocorticoid receptor
antagonists across heart failure, CKD in type 2 diabetes and emerging
type 1 diabetes evidence.
advertisment
Saturday, March 28 – Evening Events
4506. HCM Headlines Game-Changing Advances in Treatment
–
Hilton Riverside, Grand Ballroom A & B, 1st Floor Sponsored by Cytokinetics
This news-style symposium shares high-impact updates on identifying
hypertrophic cardiomyopathy and the emerging evidence on cardiac myosin
inhibition therapy to support individualized treatment.
4504. From Bench to Bedside: RNAi Therapeutics in Cardiovascular Diseases
–
New Orleans Marriott, Acadia Ballroom Sponsored by Alnylam Pharmaceuticals
This symposium explores how RNA interference has progressed from
foundational science to a clinically validated therapeutic modality in
cardiovascular disease, including ATTR-CM and future applications in
hypertension.
RNAi platform fundamentals
RNAi in cardiovascular disease
Translational applications beyond rare disease
Future directions in RNAi innovation
Speakers
Kirk Brown, PhD
Farooq Sheikh, MD, FACC
4505. Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
–
Hilton Riverside, Grand Ballroom C, 1st Floor Sponsored by Clinical Care Options, LLC dba Decera Clinical Education. Supported by an educational grant from Novartis Pharmaceuticals Corporation.
This interactive, case-based program helps clinicians integrate
lipoprotein(a) testing into routine cardiovascular risk assessment and
apply current guideline recommendations to individualized lipid-lowering
strategies.
Speakers
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Erin Michos, MD, MHS, FAHA, FACC, FASE, FASPC
Pam R. Taub, MD, FACC, FASPC
advertisment
Sunday, March 29 – Morning Events
4507. New Pathways in Antithrombotic Therapy
–
Hilton Riverside, Grand Ballroom A & B Sponsored by an educational grant from the Bristol Myers Squibb and Janssen Pharmaceuticals, Inc. Alliance.
Through immersive patient journeys and expert commentary, this
symposium helps learners make individualized, evidence-based decisions
about emerging antithrombotic strategies.
Speakers
Geoffrey D. Barnes, MD, MSc
Carolyn S. P. Lam, MBBS, PhD
Christian T. Ruff, MD, MPH
4508. Cardiac Myosin Inhibition in the Real World: What Have We Learned From Long-Term Experience in Obstructive HCM?
–
Hilton Riverside, Grand Ballroom D Sponsored by The Mended Hearts
This session reviews long-term and real-world evidence on cardiac myosin
inhibitors in obstructive hypertrophic cardiomyopathy and explores how
clinicians can apply evolving guidance in practice.
Speakers
Milind Desai, MD, MBA
Anjali Tiku Owens, MD
4509. Revolutionizing Recurrent AMI Care: Addressing Unmet Needs With Early Intervention Strategies
–
Hilton Riverside, Grand Salon B, 1st Floor Sponsored by Viatris
This fast-paced symposium discusses limitations in current care
pathways for recurrent acute myocardial infarction, the rationale for
pre-hospital antiplatelet therapies and the evolving landscape of early
intervention.
Speakers
Deepak L. Bhatt, MD, MPH, MBA
Jennifer A. Rymer, MD, MBA
Professor Philippe G. Steg, MD
advertisment
Sunday, March 29 – Evening Events
4511. Emerging Data and Evolving Guidelines, A Patient-Centered Approach to Evidence-Based Treatment For Aortic Stenosis
–
New Orleans Marriott Warehouse Arts District, Gravier Ballroom, First Floor Sponsored by Edwards Lifesciences
This symposium features a roundtable panel discussion on the latest
clinical trials and registry data in the management of aortic stenosis,
using patient case scenarios to illustrate changing care pathways.
Speakers
Sreekanth Vemulapalli, MD (Moderator)
Kashish Goel, MD, FSCAI, FACC
Tsuyoshi Kaneko, MD
Brian R. Lindman, MD, MSc
4510. The Precision Imperative: Integrating AI-Plaque Analysis to Personalize Cardiovascular Risk and Management
–
Generations Hall, 310 Andrew Higgins Blvd Sponsored by Heartflow
After participating in this program, attendees will be able to:
Recognize the growing clinical imperative to evolve cardiovascular risk assessment
Describe how Heartflow Plaque Analysis informs risk assessment and management strategies
Identify patient populations best suited for Heartflow Plaque Analysis
Speakers
Nihar Desai, MD (Moderator)
Ron Blankstein, MD
Sarah Rinehart, MD
4512. Shifting Gears in Cardio-Renal-Metabolic Care: Harnessing Evidenced-Based Therapies to Optimize Patient Outcomes
–
Hilton Riverside, Grand Ballroom C, 1st Floor Sponsored by Clinical Care Options, LLC dba Decera Clinical Education. Supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.
This program addresses hesitancy among cardiology healthcare
professionals and patients to initiate or continue evidence-based
therapies for cardio-renal-metabolic disease.
Speakers
Stephen J. Greene, MD
Ty J. Gluckman, MD, MHA
advertisment
Monday, March 30 – Morning Event
4516. Leveraging Recent Evidence on PCSK9 Inhibition: Strategies to Address Clinical Challenges For Meeting LDL-C Targets
–
Hilton Riverside, Grand Ballroom D Sponsored by The Mended Hearts, Inc. for Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.
This town hall-style symposium focuses on lipid-lowering strategies in
high-risk patients, including the latest evidence for approved and
emerging PCSK9 inhibitor approaches and team-based care strategies.
